GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dongsung Pharmaceutical Co 002210.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

1,119

+2.29%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Dongsung Pharmaceutical Co

Its shares trade on KRX under the ticker 002210.KS. It has been listed since 19 January 1990. In the fiscal year to 31 December 2025, it reported revenue of ₩87.17bn and a net loss of ₩25.74bn. At that date it held total assets of ₩168.44bn and shareholders' equity of ₩23.37bn.

Dongsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals. The company is headquartered in Seoul, Seoul. The Company’s products include anti-rheumatic, anti-inflammatory analgesics, anti-inflammatory enzymes, drugs for cardiovascular system, gastrointestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antibiotics, antidiarrheals, antifungals, oral hypoglycemic agents, hormones, hypnotics and others. The company also produces hair dyes and cosmetics. The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
19 Jan 1990
Employees
340

Leadership

Pay as last reported

  • Yang Gu LeeChief Executive Officer, Director
  • Yeon Su KimVice Chairman, since 2005
  • Jung Mu GwonVice President, Director
  • Yin Gyu KimManaging Director, since 2010
  • Sang Yi NamAssistant Managing Director
  • Tae Ri GwonInternal Auditor
  • Yong Min WonDirector
  • Jeong Man YimNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Seoul, South Korea
  • Employs 340 full-time employees
  • Produces a diverse range of pharmaceutical products including anti-rheumatic and cardiovascular drugs

Weaknesses

  • Limited to domestic and overseas market distribution
  • Relies on a narrow range of product categories
  • Operates without specified financial data or market share details

Opportunities

  • Expansion into new international markets
  • Growth in demand for pharmaceutical products
  • Potential for increased production of hair dyes and cosmetics

Threats

  • Competition from other pharmaceutical companies
  • Regulatory changes in the healthcare sector
  • Dependence on a limited number of product categories for revenue growth

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.